ABCL — AbCellera Biologics Inc. stock price, charts and financials

QT61AbCellera Biologics Inc.

AbCellera Biologics Inc. (NASDAQ: ABCL) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
9.16
+2.23+32.14%
OverviewShort InterestFilings
ABCLQT61AbCellera Biologics Inc.·NASDAQ
9.16+32.14%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 20268-KCurrent report
Aug 05, 202610-QQuarterly report
Aug 05, 20268-KCurrent report
Jul 29, 20268-KCurrent report
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20263Initial statement of beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20268-KCurrent report
Jun 17, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 12, 20268-KCurrent report
Jun 12, 20264Statement of changes in beneficial ownership
Jun 11, 20263Initial statement of beneficial ownership
Jun 05, 20268-KCurrent report
May 18, 20264Statement of changes in beneficial ownership
May 11, 20268-KCurrent report
May 11, 202610-QQuarterly report
May 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 29, 2026ARSAnnual report to shareholders
Apr 29, 2026DEF 14ADefinitive proxy statement
Apr 29, 2026DEFA14AAdditional proxy soliciting materials
Mar 02, 20264Statement of changes in beneficial ownership
Feb 27, 20264Statement of changes in beneficial ownership
Feb 27, 20264Statement of changes in beneficial ownership
#1 / 25 of 235
Page
▼
/ 10